EMF Risk assessment for AIMD and pacemaker users

Electromagnetic fields are present in many technical environments, from industrial installations to everyday infrastructure. For people using active implanted medical devices, such as pacemakers, exposure to EMF requires a structured assessment process to identify potential interference scenarios and support appropriate risk management decisions.

EMF risk assessment for AIMD users is not limited to comparing measured values with general exposure limits. It also requires an understanding of the field sources, operating conditions, exposure duration, manufacturer recommendations, physician guidance and, when necessary, detailed evaluation in complex environments.

At a glance

Why EMF risk assessment is different for AIMD users

General EMF exposure limits are designed to prevent biological effects in humans. However, these limits do not necessarily ensure electromagnetic compatibility with active implanted medical devices. In some cases, interference may still occur below general exposure limits, which is why a specific assessment approach is required for AIMD users.

The objective is to understand the electromagnetic environment, identify possible interference scenarios and determine whether additional precautions, restriction zones, monitoring tools or detailed assessment methods are required.

Level 1: General EMF assessment and exposure control

The first level consists of assessing the electromagnetic field exposure in a given environment. This initial stage applies to all individuals, not only to users of active implanted medical devices. It starts with a site analysis to identify field sources and understand their characteristics.

• Identification of electromagnetic field sources.
• Review of frequency range, field type and operating conditions.
• Evaluation of proximity to sources and exposure duration.
• Measurement under normal operating conditions and, when relevant, worst-case scenarios such as maximum power operation.

Portable EMF instrumentation, such as the Wavecontrol SMP3, is typically used to assess field levels across static fields, low frequency and RF exposure environments, with probes selected according to the application.

Based on the measurement results, exposure levels can be compared with reference limits, including general public limits and device-related thresholds where applicable. Practical actions may include defining restriction zones, marking these zones with physical indicators and documenting measurement conditions and uncertainties.

Level 2: Manufacturer and physician guidance

The second level introduces device-specific considerations. Active implanted medical devices are configured according to individual medical needs, and their response to electromagnetic fields may vary between users. For this reason, manufacturer guidance and physician recommendations are key parts of the assessment process.

• Manufacturers may provide information on device behaviour in the presence of electromagnetic fields.
• They may recommend safety distances from certain types of equipment.
• They may identify environments or devices that can cause interference.
• In some cases, manufacturer thresholds may be more restrictive than general exposure limits.

Physicians also contribute to risk management by considering the type of implanted device, its configuration and sensitivity, the individual’s medical condition, daily activities and exposure scenarios. Their recommendations may include precautions, workplace adaptations or specific evaluation procedures.

Level 3: Detailed risk assessment in complex environments

The third level applies when uncertainty remains after the general EMF assessment and device-specific guidance have been considered. This is particularly relevant in complex environments, where electromagnetic conditions may be variable or not fully characterized.

Detailed risk assessment may be necessary when:

• There is prior evidence or suspicion of interference.
• Equipment is not covered by standard compliance assumptions.
• Manufacturer or physician guidance indicates increased sensitivity.
• Workplace conditions are not fully characterized.

Detailed assessment can involve clinical or non-clinical methods. Clinical methods evaluate device behaviour under controlled conditions, with the individual present and under supervision. Non-clinical methods may include laboratory-based testing or analytical approaches, such as exposing a device to representative fields in controlled setups or estimating induced effects from known field levels and device characteristics.

Measurement and monitoring tools in the assessment workflow

Measurement and monitoring tools support the assessment process across the three levels. Portable EMF meters, such as the Wavecontrol SMP3, are used for site surveys and for quantifying exposure levels across a wide frequency range. These measurements help compare field levels with applicable limits and identify areas where additional precautions may be required.
Personal monitoring devices, such as the WaveMon LF-400, can complement the workflow by providing real-time alerts when predefined field thresholds are exceeded. However, these devices must be used with caution and should not be considered a substitute for a detailed site assessment.

• Personal monitors do not replace detailed EMF measurement campaigns.
• They do not prevent exposure; they only provide early warnings.
• They typically follow general exposure limits, which may differ from device-specific thresholds.
• For implanted device users, personal monitors should be configured according to manufacturer recommendations when used in this context.

Suggested EMF assessment workflow for AIMD users

Managing uncertainty in EMF environments

EMF risk assessment for AIMD users relies on a progressive methodology. A general assessment provides an initial understanding of exposure, while manufacturer and physician guidance allows the process to be adapted to individual conditions. In complex environments, detailed assessment methods can provide additional confidence when standard approaches are not sufficient.

For technical environments where electromagnetic exposure must be characterized, ES Canada can help identify suitable EMF measurement and monitoring instrumentation for the application, including portable EMF meters and personal monitoring solutions used as part of a structured assessment workflow.